| TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data A Colaprico, TC Silva, C Olsen, L Garofano, C Cava, D Garolini, ... Nucleic acids research 44 (8), e71-e71, 2016 | 2752 | 2016 |
| Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma M Ceccarelli, FP Barthel, TM Malta, TS Sabedot, SR Salama, BA Murray, ... Cell 164 (3), 550-563, 2016 | 1985 | 2016 |
| Proteogenomic and metabolomic characterization of human glioblastoma LB Wang, A Karpova, MA Gritsenko, JE Kyle, S Cao, Y Li, D Rykunov, ... Cancer cell 39 (4), 509-528. e20, 2021 | 390 | 2021 |
| Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma C Huang, L Chen, SR Savage, RV Eguez, Y Dou, Y Li, ... Cancer cell 39 (3), 361-379. e16, 2021 | 217 | 2021 |
| Glioblastoma hijacks neuronal mechanisms for brain invasion V Venkataramani, Y Yang, MC Schubert, E Reyhan, SK Tetzlaff, ... Cell 185 (16), 2899-2917. e31, 2022 | 194 | 2022 |
| Pathway-based classification of glioblastoma uncovers a mitochondrial subtype with therapeutic vulnerabilities L Garofano, S Migliozzi, YT Oh, F D’Angelo, RD Najac, A Ko, B Frangaj, ... Nature Cancer 2 (2), 141-156, 2021 | 194 | 2021 |
| Glioma progression is shaped by genetic evolution and microenvironment interactions FS Varn, KC Johnson, J Martinek, JT Huse, MLP Nasrallah, P Wesseling, ... Cell 185 (12), 2184-2199. e16, 2022 | 188 | 2022 |
| The molecular landscape of glioma in patients with Neurofibromatosis 1 F D’Angelo, M Ceccarelli, Tala, L Garofano, J Zhang, V Frattini, FP Caruso, ... Nature medicine 25 (1), 176-187, 2019 | 163 | 2019 |
| A metabolic function of FGFR3-TACC3 gene fusions in cancer V Frattini, SM Pagnotta, Tala, JJ Fan, MV Russo, SB Lee, L Garofano, ... Nature 553 (7687), 222-227, 2018 | 154 | 2018 |
| Treatment of metabolic acidosis with sodium bicarbonate delays progression of chronic kidney disease: the UBI Study BR Di Iorio, A Bellasi, KL Raphael, D Santoro, F Aucella, L Garofano, ... Journal of nephrology 32, 989-1001, 2019 | 153 | 2019 |
| RGBM: regularized gradient boosting machines for identification of the transcriptional regulators of discrete glioma subtypes R Mall, L Cerulo, L Garofano, V Frattini, K Kunji, H Bensmail, TS Sabedot, ... Nucleic acids research 46 (7), e39-e39, 2018 | 50 | 2018 |
| A map of tumor–host interactions in glioma at single-cell resolution FP Caruso, L Garofano, F D'Angelo, K Yu, F Tang, J Yuan, J Zhang, ... Gigascience 9 (10), giaa109, 2020 | 37 | 2020 |
| Integrative multi-omics networks identify PKCδ and DNA-PK as master kinases of glioblastoma subtypes and guide targeted cancer therapy S Migliozzi, YT Oh, M Hasanain, L Garofano, F D’Angelo, RD Najac, ... Nature Cancer 4 (2), 181-202, 2023 | 19 | 2023 |
| Temporospatial genomic profiling in glioblastoma identifies commonly altered core pathways underlying tumor progression MR Blomquist, SF Ensign, F D’Angelo, JJ Phillips, M Ceccarelli, S Peng, ... Neuro-oncology advances 2 (1), vdaa078, 2020 | 16 | 2020 |
| EPCO-09. LONGITUDINAL ANALYSIS OF DIFFUSE GLIOMA REVEALS CELL STATE DYNAMICS AT RECURRENCE ASSOCIATED WITH CHANGES IN GENETICS AND THE MICROENVIRONMENT F Varn, K Johnson, T Wade, T Malta, T Sabedot, F Barthel, H Kim, ... Neuro-Oncology 23 (Supplement_6), vi3-vi3, 2021 | 14* | 2021 |
| Integrated proteogenomic characterization of glioblastoma evolution KH Kim, S Migliozzi, H Koo, JH Hong, SM Park, S Kim, HJ Kwon, S Ha, ... Cancer Cell, 2024 | 3 | 2024 |
| Regulated interaction of ID2 with the anaphase-promoting complex links progression through mitosis with reactivation of cell-type-specific transcription SB Lee, L Garofano, A Ko, F D’Angelo, B Frangaj, D Sommer, Q Gan, ... Nature Communications 13 (1), 2089, 2022 | 2 | 2022 |
| The epigenetic evolution of glioma is determined by the IDH1 mutation status and treatment regimen TM Malta, TS Sabedot, NS Morosini, I Datta, L Garofano, W Vallentgoed, ... Cancer research 84 (5), 741-756, 2024 | 1 | 2024 |
| The epigenetic evolution of gliomas is determined by their IDH1 mutation status and treatment regimen TM Malta, TS Sabedot, I Datta, L Garofano, W Vallentgoed, FS Varn, ... bioRxiv, 2021.08. 09.455687, 2021 | 1 | 2021 |
| OMRT-3. Longitudinal analysis of diffuse glioma reveals cell state dynamics at recurrence associated with changes in genetics and the microenvironment F Varn, K Johnson, F Barthel, H Kim, T Wade, T Malta, T Sabedot, ... Neuro-Oncology Advances 3 (Supplement_2), ii7-ii8, 2021 | 1 | 2021 |
